APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Motility Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastrointestinal Motility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchGastrointestinal Motility Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Motility Drugs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Motility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Motility Drugs Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Motility Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Gastrointestinal Motility Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal Motility Drugs include Zhuhai Rundu Pharmaceutical Co., Ltd., Yabao Pharmaceutical Group Co., Ltd., Sichuan Zilinggong Pharmaceutical Co., Ltd., Shijiazhuang Siyao Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd. and Jiangsu Jibei Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastrointestinal Motility Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal Motility Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal Motility Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastrointestinal Motility Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastrointestinal Motility Drugs Segment by Company

Zhuhai Rundu Pharmaceutical Co., Ltd.

Yabao Pharmaceutical Group Co., Ltd.

Sichuan Zilinggong Pharmaceutical Co., Ltd.

Shijiazhuang Siyao Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Jiangxi Huiren Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

China Resources Double Crane Pharmaceutical Co., Ltd.

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.

Hainan Asia Pharmaceutical Co., Ltd.

Guangdong Annuo Pharmaceutical Co., Ltd.

Disa Pharmaceutical Group Co., Ltd.

Chenxin Pharmaceutical Co., Ltd.

Taj Pharmaceuticals Limited

Sumitomo Pharma Co., Ltd.

Pfizer

Midas Pharma GmbH

Janssen Pharmaceutica

Hanmi Pharm. Co., Ltd.

ANI Pharmaceuticals, Inc.

Abbott

Gastrointestinal Motility Drugs Segment by Type

Domperidone

Metoclopramide

Mosapride

Minaprocaine Bromide

Itopride

Gastrointestinal Motility Drugs Segment by Application

Clinic

Hospital

Other

Gastrointestinal Motility Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Motility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Motility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Motility Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastrointestinal Motility Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gastrointestinal Motility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gastrointestinal Motility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gastrointestinal Motility Drugs Industry Trends Table 2. Gastrointestinal Motility Drugs Industry Drivers Table 3. Gastrointestinal Motility Drugs Industry Opportunities and Challenges Table 4. Gastrointestinal Motility Drugs Industry Restraints Table 5. Global Gastrointestinal Motility Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gastrointestinal Motility Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gastrointestinal Motility Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gastrointestinal Motility Drugs Sales Market Share by Manufacturers Table 9. Global Gastrointestinal Motility Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gastrointestinal Motility Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gastrointestinal Motility Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gastrointestinal Motility Drugs Manufacturers, Product Type & Application Table 13. Global Gastrointestinal Motility Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastrointestinal Motility Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Domperidone Table 17. Major Manufacturers of Metoclopramide Table 18. Major Manufacturers of Mosapride Table 19. Major Manufacturers of Minaprocaine Bromide Table 20. Major Manufacturers of Itopride Table 21. Global Gastrointestinal Motility Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Gastrointestinal Motility Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Gastrointestinal Motility Drugs Sales Market Share by Type (2021-2026) Table 25. Global Gastrointestinal Motility Drugs Sales Market Share by Type (2027-2032) Table 26. Global Gastrointestinal Motility Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Gastrointestinal Motility Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Gastrointestinal Motility Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Other Table 34. Global Gastrointestinal Motility Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Gastrointestinal Motility Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Gastrointestinal Motility Drugs Sales Market Share by Application (2021-2026) Table 38. Global Gastrointestinal Motility Drugs Sales Market Share by Application (2027-2032) Table 39. Global Gastrointestinal Motility Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Gastrointestinal Motility Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Gastrointestinal Motility Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Gastrointestinal Motility Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Gastrointestinal Motility Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Gastrointestinal Motility Drugs Sales Market Share by Region (2021-2026) Table 47. Global Gastrointestinal Motility Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Gastrointestinal Motility Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Gastrointestinal Motility Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Gastrointestinal Motility Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Gastrointestinal Motility Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Gastrointestinal Motility Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Gastrointestinal Motility Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Gastrointestinal Motility Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Gastrointestinal Motility Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Gastrointestinal Motility Drugs Revenue Market Share by Region (2027-2032) Table 66. Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information Table 67. Zhuhai Rundu Pharmaceutical Co., Ltd. Business Overview Table 68. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 70. Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Development Table 71. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 72. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 73. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 75. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 76. Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information Table 77. Sichuan Zilinggong Pharmaceutical Co., Ltd. Business Overview Table 78. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 80. Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Development Table 81. Shijiazhuang Siyao Co., Ltd. Company Information Table 82. Shijiazhuang Siyao Co., Ltd. Business Overview Table 83. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 85. Shijiazhuang Siyao Co., Ltd. Recent Development Table 86. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 87. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 88. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 90. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 91. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 92. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 93. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 95. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Development Table 96. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 97. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 98. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 100. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 101. Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information Table 102. Jiangxi Huiren Pharmaceutical Co., Ltd. Business Overview Table 103. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 105. Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Development Table 106. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 107. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 108. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 110. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 111. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 112. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 113. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 115. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 116. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information Table 117. China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview Table 118. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 120. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Development Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Development Table 126. Hainan Asia Pharmaceutical Co., Ltd. Company Information Table 127. Hainan Asia Pharmaceutical Co., Ltd. Business Overview Table 128. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 130. Hainan Asia Pharmaceutical Co., Ltd. Recent Development Table 131. Guangdong Annuo Pharmaceutical Co., Ltd. Company Information Table 132. Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview Table 133. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 135. Guangdong Annuo Pharmaceutical Co., Ltd. Recent Development Table 136. Disa Pharmaceutical Group Co., Ltd. Company Information Table 137. Disa Pharmaceutical Group Co., Ltd. Business Overview Table 138. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 140. Disa Pharmaceutical Group Co., Ltd. Recent Development Table 141. Chenxin Pharmaceutical Co., Ltd. Company Information Table 142. Chenxin Pharmaceutical Co., Ltd. Business Overview Table 143. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 145. Chenxin Pharmaceutical Co., Ltd. Recent Development Table 146. Taj Pharmaceuticals Limited Company Information Table 147. Taj Pharmaceuticals Limited Business Overview Table 148. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product Portfolio Table 150. Taj Pharmaceuticals Limited Recent Development Table 151. Sumitomo Pharma Co., Ltd. Company Information Table 152. Sumitomo Pharma Co., Ltd. Business Overview Table 153. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 155. Sumitomo Pharma Co., Ltd. Recent Development Table 156. Pfizer Company Information Table 157. Pfizer Business Overview Table 158. Pfizer Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Pfizer Gastrointestinal Motility Drugs Product Portfolio Table 160. Pfizer Recent Development Table 161. Midas Pharma GmbH Company Information Table 162. Midas Pharma GmbH Business Overview Table 163. Midas Pharma GmbH Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Midas Pharma GmbH Gastrointestinal Motility Drugs Product Portfolio Table 165. Midas Pharma GmbH Recent Development Table 166. Janssen Pharmaceutica Company Information Table 167. Janssen Pharmaceutica Business Overview Table 168. Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Janssen Pharmaceutica Gastrointestinal Motility Drugs Product Portfolio Table 170. Janssen Pharmaceutica Recent Development Table 171. Hanmi Pharm. Co., Ltd. Company Information Table 172. Hanmi Pharm. Co., Ltd. Business Overview Table 173. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 175. Hanmi Pharm. Co., Ltd. Recent Development Table 176. ANI Pharmaceuticals, Inc. Company Information Table 177. ANI Pharmaceuticals, Inc. Business Overview Table 178. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product Portfolio Table 180. ANI Pharmaceuticals, Inc. Recent Development Table 181. Abbott Company Information Table 182. Abbott Business Overview Table 183. Abbott Gastrointestinal Motility Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. Abbott Gastrointestinal Motility Drugs Product Portfolio Table 185. Abbott Recent Development Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Gastrointestinal Motility Drugs Distributors List Table 189. Gastrointestinal Motility Drugs Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Gastrointestinal Motility Drugs Product Image Figure 2. Global Gastrointestinal Motility Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Motility Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal Motility Drugs Sales (2021-2032) & (K Units) Figure 5. Global Gastrointestinal Motility Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gastrointestinal Motility Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Domperidone Image Figure 9. Metoclopramide Image Figure 10. Mosapride Image Figure 11. Minaprocaine Bromide Image Figure 12. Itopride Image Figure 13. Global Gastrointestinal Motility Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Gastrointestinal Motility Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gastrointestinal Motility Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Gastrointestinal Motility Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Gastrointestinal Motility Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Other Image Figure 22. Global Gastrointestinal Motility Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Gastrointestinal Motility Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gastrointestinal Motility Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Gastrointestinal Motility Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Gastrointestinal Motility Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2032) Figure 42. China Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Gastrointestinal Motility Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Gastrointestinal Motility Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Gastrointestinal Motility Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Gastrointestinal Motility Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Gastrointestinal Motility Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Gastrointestinal Motility Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Gastrointestinal Motility Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Gastrointestinal Motility Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gastrointestinal Motility Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Domperidone
  • Metoclopramide
  • Mosapride
  • Minaprocaine Bromide
  • Itopride
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Zhuhai Rundu Pharmaceutical Co., Ltd.
  • Yabao Pharmaceutical Group Co., Ltd.
  • Sichuan Zilinggong Pharmaceutical Co., Ltd.
  • Shijiazhuang Siyao Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • China Resources Double Crane Pharmaceutical Co., Ltd.
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  • Hainan Asia Pharmaceutical Co., Ltd.
  • Guangdong Annuo Pharmaceutical Co., Ltd.
  • Disa Pharmaceutical Group Co., Ltd.
  • Chenxin Pharmaceutical Co., Ltd.
  • Taj Pharmaceuticals Limited
  • Sumitomo Pharma Co., Ltd.
  • Pfizer
  • Midas Pharma GmbH
  • Janssen Pharmaceutica
  • Hanmi Pharm. Co., Ltd.
  • ANI Pharmaceuticals, Inc.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastrointestinal Motility Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastrointestinal Motility Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gastrointestinal Motility Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gastrointestinal Motility Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gastrointestinal Motility Drugs Market Dynamics
  1. 2.1 Gastrointestinal Motility Drugs Industry Trends
  2. 2.2 Gastrointestinal Motility Drugs Industry Drivers
  3. 2.3 Gastrointestinal Motility Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Motility Drugs Industry Restraints
3 Gastrointestinal Motility Drugs Market by Manufacturers
  1. 3.1 Global Gastrointestinal Motility Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gastrointestinal Motility Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gastrointestinal Motility Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gastrointestinal Motility Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal Motility Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gastrointestinal Motility Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Gastrointestinal Motility Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal Motility Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal Motility Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal Motility Drugs Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Motility Drugs Market by Type
  1. 4.1 Gastrointestinal Motility Drugs Type Introduction
  2. 4.1.1 Domperidone
  3. 4.1.2 Metoclopramide
  4. 4.1.3 Mosapride
  5. 4.1.4 Minaprocaine Bromide
  6. 4.1.5 Itopride
  7. 4.2 Global Gastrointestinal Motility Drugs Sales by Type
  8. 4.2.1 Global Gastrointestinal Motility Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Gastrointestinal Motility Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Gastrointestinal Motility Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Gastrointestinal Motility Drugs Revenue by Type
  12. 4.3.1 Global Gastrointestinal Motility Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Gastrointestinal Motility Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2021-2032)
5 Gastrointestinal Motility Drugs Market by Application
  1. 5.1 Gastrointestinal Motility Drugs Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Gastrointestinal Motility Drugs Sales by Application
  6. 5.2.1 Global Gastrointestinal Motility Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal Motility Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Gastrointestinal Motility Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gastrointestinal Motility Drugs Revenue by Application
  10. 5.3.1 Global Gastrointestinal Motility Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gastrointestinal Motility Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2021-2032)
6 Global Gastrointestinal Motility Drugs Sales by Region
  1. 6.1 Global Gastrointestinal Motility Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastrointestinal Motility Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gastrointestinal Motility Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Gastrointestinal Motility Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gastrointestinal Motility Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gastrointestinal Motility Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gastrointestinal Motility Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gastrointestinal Motility Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gastrointestinal Motility Drugs Revenue by Region
  1. 7.1 Global Gastrointestinal Motility Drugs Revenue by Region
  2. 7.1.1 Global Gastrointestinal Motility Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gastrointestinal Motility Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Gastrointestinal Motility Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Gastrointestinal Motility Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gastrointestinal Motility Drugs Revenue (2021-2032)
  8. 7.2.2 North America Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gastrointestinal Motility Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gastrointestinal Motility Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gastrointestinal Motility Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gastrointestinal Motility Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhuhai Rundu Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhuhai Rundu Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  6. 8.1.5 Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Yabao Pharmaceutical Group Co., Ltd.
  8. 8.2.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  9. 8.2.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  10. 8.2.3 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  12. 8.2.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  13. 8.3 Sichuan Zilinggong Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Zilinggong Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  18. 8.3.5 Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shijiazhuang Siyao Co., Ltd.
  20. 8.4.1 Shijiazhuang Siyao Co., Ltd. Company Information
  21. 8.4.2 Shijiazhuang Siyao Co., Ltd. Business Overview
  22. 8.4.3 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  24. 8.4.5 Shijiazhuang Siyao Co., Ltd. Recent Developments
  25. 8.5 Shandong Xinhua Pharmaceutical Co., Ltd.
  26. 8.5.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  30. 8.5.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shandong Fangming Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  36. 8.6.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Lunan Beite Pharmaceutical Co., Ltd.
  38. 8.7.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  42. 8.7.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jiangxi Huiren Pharmaceutical Co., Ltd.
  44. 8.8.1 Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jiangxi Huiren Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  48. 8.8.5 Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jiangsu Jibei Pharmaceutical Co., Ltd.
  50. 8.9.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  54. 8.9.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  56. 8.10.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  57. 8.10.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  58. 8.10.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  60. 8.10.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  61. 8.11 China Resources Double Crane Pharmaceutical Co., Ltd.
  62. 8.11.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  66. 8.11.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  68. 8.12.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  72. 8.12.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Hainan Asia Pharmaceutical Co., Ltd.
  74. 8.13.1 Hainan Asia Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hainan Asia Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  78. 8.13.5 Hainan Asia Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Guangdong Annuo Pharmaceutical Co., Ltd.
  80. 8.14.1 Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  84. 8.14.5 Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Disa Pharmaceutical Group Co., Ltd.
  86. 8.15.1 Disa Pharmaceutical Group Co., Ltd. Company Information
  87. 8.15.2 Disa Pharmaceutical Group Co., Ltd. Business Overview
  88. 8.15.3 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  90. 8.15.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments
  91. 8.16 Chenxin Pharmaceutical Co., Ltd.
  92. 8.16.1 Chenxin Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Chenxin Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  96. 8.16.5 Chenxin Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Taj Pharmaceuticals Limited
  98. 8.17.1 Taj Pharmaceuticals Limited Company Information
  99. 8.17.2 Taj Pharmaceuticals Limited Business Overview
  100. 8.17.3 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product Portfolio
  102. 8.17.5 Taj Pharmaceuticals Limited Recent Developments
  103. 8.18 Sumitomo Pharma Co., Ltd.
  104. 8.18.1 Sumitomo Pharma Co., Ltd. Company Information
  105. 8.18.2 Sumitomo Pharma Co., Ltd. Business Overview
  106. 8.18.3 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  108. 8.18.5 Sumitomo Pharma Co., Ltd. Recent Developments
  109. 8.19 Pfizer
  110. 8.19.1 Pfizer Company Information
  111. 8.19.2 Pfizer Business Overview
  112. 8.19.3 Pfizer Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Pfizer Gastrointestinal Motility Drugs Product Portfolio
  114. 8.19.5 Pfizer Recent Developments
  115. 8.20 Midas Pharma GmbH
  116. 8.20.1 Midas Pharma GmbH Company Information
  117. 8.20.2 Midas Pharma GmbH Business Overview
  118. 8.20.3 Midas Pharma GmbH Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Midas Pharma GmbH Gastrointestinal Motility Drugs Product Portfolio
  120. 8.20.5 Midas Pharma GmbH Recent Developments
  121. 8.21 Janssen Pharmaceutica
  122. 8.21.1 Janssen Pharmaceutica Company Information
  123. 8.21.2 Janssen Pharmaceutica Business Overview
  124. 8.21.3 Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Janssen Pharmaceutica Gastrointestinal Motility Drugs Product Portfolio
  126. 8.21.5 Janssen Pharmaceutica Recent Developments
  127. 8.22 Hanmi Pharm. Co., Ltd.
  128. 8.22.1 Hanmi Pharm. Co., Ltd. Company Information
  129. 8.22.2 Hanmi Pharm. Co., Ltd. Business Overview
  130. 8.22.3 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  132. 8.22.5 Hanmi Pharm. Co., Ltd. Recent Developments
  133. 8.23 ANI Pharmaceuticals, Inc.
  134. 8.23.1 ANI Pharmaceuticals, Inc. Company Information
  135. 8.23.2 ANI Pharmaceuticals, Inc. Business Overview
  136. 8.23.3 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product Portfolio
  138. 8.23.5 ANI Pharmaceuticals, Inc. Recent Developments
  139. 8.24 Abbott
  140. 8.24.1 Abbott Company Information
  141. 8.24.2 Abbott Business Overview
  142. 8.24.3 Abbott Gastrointestinal Motility Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Abbott Gastrointestinal Motility Drugs Product Portfolio
  144. 8.24.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastrointestinal Motility Drugs Value Chain Analysis
  2. 9.1.1 Gastrointestinal Motility Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastrointestinal Motility Drugs Production Mode & Process
  6. 9.2 Gastrointestinal Motility Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastrointestinal Motility Drugs Distributors
  9. 9.2.3 Gastrointestinal Motility Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst